A research paper done by a Harvard professor showed the employment rate for women rose by 27% after taking GLP-1s.

In a target trial emulation, getting a COVID and flu shot on the same day was not associated with an increased risk of ...

Women who were vaccinated against covid-19 in the luteal phase of their menstrual cycle reported having a breakthrough ...

A post-marketing trial finds the oral antiviral achieves effective blood concentrations in at-risk children aged 6 years or older with mild-to-moderate COVID.

Pfizer has reported topline data from the Phase III SigVie-002 study investigating sigvotatug vedotin in adults with ...

Pfizer Inc. said an experimental drug failed to improve survival in patients with an advanced form of lung cancer that couldn ...

Pfizer said on Monday that one ‌of the key experimental drugs it picked up in its $43 billion 2023 acquisition of Seagen ...

Pfizer (PFE) stock is in focus as the antibody-drug conjugate sigvotatug vedotin fails in a Phase 3 trial versus chemotherapy ...

Despite an overall survival miss, Leerink Partners said Pfizer’s antibody-drug conjugate showed “promising” signals of efficacy in a subgroup of patients who had undergone only one prior line of ...

Pfizer will receive an exclusive global license for four programs. (cybrain/Getty Images) Pfizer is paying Innovent $650 million upfront to partner on cancer drug development, following Bristol Myers ...

May 20 (Reuters) - Pfizer (PFE.N), opens new tab said on Wednesday its experimental pneumococcal vaccine showed significantly stronger immune response than its current shot, including up to 15-fold ...

Phase 2 data demonstrate robust immunogenicity, including enhanced response against serotype 3, alongside expanded protection across 25 serotypes; to achieve potential vaccine serotype coverage of 90% ...